Literature DB >> 12269835

Ligand binding properties and structural studies of recombinant and chemically modified hemoglobins altered at beta 93 cysteine.

Yi Cheng1, Tong-Jian Shen, Virgil Simplaceanu, Chien Ho.   

Abstract

To investigate the roles of beta93 cysteine in human normal adult hemoglobin (Hb A), we have constructed four recombinant mutant hemoglobins (rHbs), rHb (betaC93G), rHb (betaC93A), rHb (betaC93M), and rHb (betaC93L), and have prepared two chemically modified Hb As, Hb A-IAA and Hb A-NEM, in which the sulfhydryl group at beta93Cys is modified by sulfhydryl reagents, iodoacetamide (IAA) and N-ethylmaleimide (NEM), respectively. These variants at the beta93 position show higher oxygen affinity, lower cooperativity, and reduced Bohr effect relative to Hb A. The response of some of these Hb variants to allosteric effectors, 2,3-bisphosphoglycerate (2,3-BPG) and inositol hexaphosphate (IHP), is decreased relative to that of Hb A. The proton nuclear magnetic resonance (NMR) spectra of these Hb variants show that there is a marked influence on the proximal heme pocket of the beta-chain, whereas the environment of the proximal heme pocket of the alpha-chain remains unchanged as compared to Hb A, suggesting that higher oxygen affinity is likely to be determined by the heme pocket of the beta-chain rather than by that of the alpha-chain. This is further supported by NO titration of these Hbs in the deoxy form. For Hb A, NO binds preferentially to the heme of the alpha-chain relative to that of the beta-chain. In contrast, the feature of preferential binding to the heme of the alpha-chain becomes weaker and even disappears for Hb variants with modifications at beta93Cys. The effects of IHP on these Hbs in the NO form are different from those on HbNO A, as characterized by (1)H NMR spectra of the T-state markers, the exchangeable resonances at 14 and 11 ppm, reflecting that these Hb variants have more stability in the R-state relative to Hb A, especially rHb (betaC93L) and Hb A-NEM in the NO form. The changes of the C2 proton resonances of the surface histidyl residues in these Hb variants in both the deoxy and CO forms, compared with those of Hb A, indicate that a mutation or chemical modification at beta93Cys can result in conformational changes involving several surface histidyl residues, e.g., beta146His and beta2His. The results obtained here offer strong evidence to show that the salt bridge between beta146His and beta94Asp and the binding pocket of allosteric effectors can be affected as the result of modifications at beta93Cys, which result in the destabilization of the T-state and a reduced response of these Hbs to allosteric effectors. We further propose that the impaired alkaline Bohr effect can be attributed to the effect on the contributions of several surface histidyl residues which are altered because of the environmental changes caused by mutations and chemical modifications at beta93Cys.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12269835     DOI: 10.1021/bi0202880

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  The role of beta93 Cys in the inhibition of Hb S fiber formation.

Authors:  Kelly M Knee; Catherine K Roden; Mark R Flory; Ishita Mukerji
Journal:  Biophys Chem       Date:  2007-02-16       Impact factor: 2.352

2.  A new paramagnetic intermediate formed during the reaction of nitrite with deoxyhemoglobin.

Authors:  Maria T Salgado; Somasundaram Ramasamy; Antonio Tsuneshige; Periakaruppan T Manoharan; Joseph M Rifkind
Journal:  J Am Chem Soc       Date:  2011-08-02       Impact factor: 15.419

3.  Conjugation of multiple copies of polyethylene glycol to hemoglobin facilitated through thiolation: influence on hemoglobin structure and function.

Authors:  Belur N Manjula; Amy G Tsai; Marcos Intaglietta; Ching-Hsuan Tsai; Chien Ho; Paul K Smith; Krishnaveni Perumalsamy; Nirmala Devi Kanika; Joel M Friedman; Seetharama A Acharya
Journal:  Protein J       Date:  2005-04       Impact factor: 2.371

4.  Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation.

Authors:  Jack H Crawford; T Scott Isbell; Zhi Huang; Sruti Shiva; Balu K Chacko; Alan N Schechter; Victor M Darley-Usmar; Jeffrey D Kerby; John D Lang; David Kraus; Chien Ho; Mark T Gladwin; Rakesh P Patel
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

5.  Structure-function relationship in a variant hemoglobin: a combined computational-experimental approach.

Authors:  Matteo Ceccarelli; Paolo Ruggerone; Roberto Anedda; Antonella Fais; Benedetta Era; Maria Carla Sollaino; Marcella Corda; Mariano Casu
Journal:  Biophys J       Date:  2006-07-14       Impact factor: 4.033

Review 6.  βCysteine 93 in human hemoglobin: a gateway to oxidative stability in health and disease.

Authors:  Abdu I Alayash
Journal:  Lab Invest       Date:  2020-09-26       Impact factor: 5.662

7.  Kinetics of NO and O2 binding to a maleimide poly(ethylene glycol)-conjugated human haemoglobin.

Authors:  Kim D Vandegriff; Andrea Bellelli; Michele Samaja; Ashok Malavalli; Maurizio Brunori; Robert M Winslow
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

8.  Site-selective glycosylation of hemoglobin on Cys beta93.

Authors:  Yalong Zhang; Veer S Bhatt; Guoyong Sun; Peng G Wang; Andre F Palmer
Journal:  Bioconjug Chem       Date:  2008-11-19       Impact factor: 4.774

9.  SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation.

Authors:  T Scott Isbell; Chiao-Wang Sun; Li-Chen Wu; Xinjun Teng; Dario A Vitturi; Billy G Branch; Christopher G Kevil; Ning Peng; J Michael Wyss; Namasivayam Ambalavanan; Lisa Schwiebert; Jinxiang Ren; Kevin M Pawlik; Matthew B Renfrow; Rakesh P Patel; Tim M Townes
Journal:  Nat Med       Date:  2008-05-30       Impact factor: 53.440

10.  Expression and purification of recombinant hemoglobin in Escherichia coli.

Authors:  Chandrasekhar Natarajan; Xiaoben Jiang; Angela Fago; Roy E Weber; Hideaki Moriyama; Jay F Storz
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.